MORI Jo | Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
スポンサーリンク
概要
- MORI Joの詳細を見る
- 同名の論文著者
- Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.の論文著者
関連著者
-
MORI Jo
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
SATOH Hisashi
Department of Biochemical Pharmacology, Faculty of Pharmaceutical Sciences University of Chiba
-
Takakura Shoji
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Nakamura Takaaki
Department Of Anatomy Shiga University Of Medical Science
-
Handa Jyoji
Department Of Anatomy And Neurosurgery Shiga University Of Medical Science
-
Matsumoto Sanae
Department Of Anesthesiology Kansai Medical University
-
Tomoi Masaaki
Department Of Metabolic Diseases Medicinal Biology Research Laboratories
-
Shimomura Kyoichi
Department Of Pharmacology Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hatakeyama Yoshifumi
Department Of Pharmacology Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Motoyama Yukio
Department Of Immunology And Inflammation Medicinal Biology Research Laboratories Fujisawa Pharmaceu
-
Shiino Akihiko
Department Of Neurosurgery Shiga University Of Medical Science
-
Fujii Takashi
Department Of Applied Physics And Chemistry The University Of Electro-communications
-
Matsuo Masahiko
Department Of Biology Faculty Of Science Kobe University
-
SHIBAYAMA Fumio
Department of Pharmacology, Toho University School of Medicine
-
MANDA Toshitaka
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokyo
-
Kohsaka Masanobu
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Kohsaka Masanobu
Department of Pharmacology, Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Hatakeyama Yoshifumi
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
HIROI Jun
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Hiroi Jun
Department of Pharmacology, Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
OHARA Kaname
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
KOBAYASHI Katsumasa
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
FUJITSU Takashi
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Kobayashi Katsumasa
Department of Pharmacology, Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
NAKAMURA Takaaki
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Furuichi Yasuhisa
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
MOTOYAMA Yukio
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Matsuo Masahiko
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
MASUDA Kikuo
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
OKU Toshiko
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
SHIBAYAMA Fumio
Department of Pharmacology, Faculty of Medicine, University of Tokyo
-
SHIBAYAMA Fumio
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Handa Jyoji
Department of Neurosurgery, Shiga University of Medical Sciences
-
Susumu Teruo
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
FUJII Takashi
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
著作論文
- Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.
- The Effect of Nilvadipine, a Dihydropyridine Type Calcium Channel Blocker, on Local Cerebral Blood Flow in Rats.
- Multiple Mediators and Mechanisms Are Involved in the Adaptive Cytoprotection Provided by Certain Mild Irritants.
- Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.
- Nilvadipine, a New Calcium Channel Blocker, Reduces Ischemic Brain Injury in Rats.